ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0383

Analysis of the Performance of an Artificial Intelligence Algorithm for the Detection of Radiographic Sacroiliitis in an Independent Cohort of axSpA Patients Including Both Nr-axSpA and r-axSpA

Fabian Proft1, Janis Vahldiek2, Joeri Nicolaes3, Rachel Tham4, Bengt Hoepken5, Baran Ufuktepe6, Denis Poddubnyy1 and Keno Kyrill Bressem2, 1Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, Berlin, Germany, 2Charité – Universitätsmedizin Berlin, Berlin, Germany, 3UCB Pharma, Anderlecht, Belgium, 4UCB Pharma, Slough, UK, Overland Park, KS, 5UCB Pharma, Monheim am Rhein, Germany, 6UCB Pharma A.S., Istanbul, Turkey

Meeting: ACR Convergence 2022

Keywords: Ankylosing spondylitis (AS), Bioinformatics, Health Care, Imaging, X-ray

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Conventional radiography of the sacroiliac joints is the first imaging method if axial spondyloarthritis (axSpA) is suspected. The presence of definite radiographic sacroiliitis is needed to classify as radiographic (r-axSpA) based on the modified New York Criteria (mNYc). However, the reliability of radiographic sacroiliitis assessment is low, especially if performed locally. Expert central reading for classification purposes in clinical trials is time-consuming and still has high inter-reader variability.

A possible solution to detect radiographic sacroiliitis with consistent reproducibility, could be the use of an artificial intelligence analysis of radiographs. Recently an artificial neural network showed an expert-level performance for classification and diagnostic settings1,2.

The aim of this study was to evaluate the performance of this previously trained artificial network in a completely new cohort of patients previously evaluated as r-axSpA or nr-axSpA by central readers.

Methods: Baseline radiographs of sacroiliac joints from RAPID-axSpA (NCT01087762, N=277) were evaluated by 3 central reader experts and the majority decision of fulfillment the mNYc was used as a reference. None of the patients nor any of the central readers participated in the studies used to pre-train the artificial network.

For performance evaluation of the neural network, the area under the receiver operating characteristic curve (AUROC) was calculated. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for the prediction cut-offs were calculated along with their 95% Confidence Intervals (CI) using accelerated bootstrapping. Cohen’s Kappa and the absolute agreement were used to assess the agreement between the neural network and the human readers.

Results: Baseline characteristics are presented in table 1. Sensitivity and specificity for the cut-off weighting both measurements were 0.82 (95% CI: 0.78, 0.86) and 0.81 (95% CI: 0.75, 0.87). The Cohen’s kappa between the neural network and the reference judgements was 0.61 (95% CI: 0.51, 0.70), and the absolute agreement on the classification yielded 82% (95% CI: 0.78, 0.85). The neural network achieved an 0.89 (95% CI: 0.86, 0.93) PPV and a 0.70 (95% CI: 0.64, 0.77) NPV in recognition of definite radiographic sacroiliitis with AUROC of 0.88 (Figure 1).

Conclusion: A pre-trained artificial neural network can enable the accurate detection of definite radiographic sacroiliitis relevant for the diagnosis and classification of axSpA close to expert performance. In the present study, the previously trained network showed an excellent ability to generalize data that was completely new to the network. Our results show the potential for classification purposes in multi-center axSpA trials in the future, providing a reproducible and cost-effective tool without unnecessary time delays.

Supporting image 1

Table 1: ASDAS: Ankylosing Spondylitis Disease Activity Score; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; BASFI: Bath Ankylosing Spondylitis Functional Index; BASMI: Bath Ankylosing Spondylitis Metrology Index; BMI: body mass index; CRP: C-reactive protein; HLA-B27: human leukocyte antigen B27; nr-axSpA: non-radiographic axial spondyloarthritis; r-axSpA: radiographic axial spondyloarthritis; SD: standard deviation.

Supporting image 2

Figure 1. Area Under the Receiver Operating Characteristic Curve for
Evaluating Performance of the Neural Network to Detect Radiographic Sacroiliitis


Disclosures: F. Proft, AbbVie/Abbott, Amgen, Bristol-Myers Squibb(BMS), Celgene, Eli Lilly, Janssen, Merck/MSD, Novartis, Pfizer, Roche, UCB; J. Vahldiek, None; J. Nicolaes, UCB; R. Tham, UCB Pharma, Veramed; B. Hoepken, UCB Pharma; B. Ufuktepe, UCB; D. Poddubnyy, AbbVie, Biocad, Bristol-Myers Squibb, Eli Lilly, Gilead, GlaxoSmithKline, MSD, Moonlake, Novartis, Pfizer, Samsung-Bioepis, UCB; K. Bressem, None.

To cite this abstract in AMA style:

Proft F, Vahldiek J, Nicolaes J, Tham R, Hoepken B, Ufuktepe B, Poddubnyy D, Bressem K. Analysis of the Performance of an Artificial Intelligence Algorithm for the Detection of Radiographic Sacroiliitis in an Independent Cohort of axSpA Patients Including Both Nr-axSpA and r-axSpA [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/analysis-of-the-performance-of-an-artificial-intelligence-algorithm-for-the-detection-of-radiographic-sacroiliitis-in-an-independent-cohort-of-axspa-patients-including-both-nr-axspa-and-r-axspa/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/analysis-of-the-performance-of-an-artificial-intelligence-algorithm-for-the-detection-of-radiographic-sacroiliitis-in-an-independent-cohort-of-axspa-patients-including-both-nr-axspa-and-r-axspa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology